Bagmetova V V, Chernysheva Iu V, Merkushenkova O V, Berestovitskaia V M, Tiurenkov I N
Eksp Klin Farmakol. 2013;76(3):7-9.
The new glutamic acid derivative--beta-phenylglutamic acid hydrochloride (RGPU-135, glutarone) (in a dose of 26 mg/kg), imipramine (15 mg/kg), tianeptine (2.5 mg/kg) and fluoxetine (20 mg/kg), show antidepressant action in the tail suspension test and Porsolt swim test. All these drugs cause reduction in the intensity of depressive behavior and lead to increase in the rate of active behavior of avoidance of aversive situation with animals. The RGPU-135 compound shows antidepressant activity equal to that of imipramine, which is statistically significantly more pronounced than that of fluoxetine and tianeptine.
新型谷氨酸衍生物——盐酸β-苯基谷氨酸(RGPU-135,戊二酮)(剂量为26毫克/千克)、丙咪嗪(15毫克/千克)、噻奈普汀(2.5毫克/千克)和氟西汀(20毫克/千克),在悬尾试验和波索尔特游泳试验中均显示出抗抑郁作用。所有这些药物均能降低抑郁行为的强度,并导致动物在回避厌恶情境时主动行为的速率增加。RGPU-135化合物显示出与丙咪嗪相当的抗抑郁活性,在统计学上,其抗抑郁活性明显强于氟西汀和噻奈普汀。